期刊文献+

丁咯地尔血药浓度的高效液相色谱法测定及其药动学 被引量:2

Determination of buflomedil in serum by HPLC and study on its pharmacokinetics
下载PDF
导出
摘要 目的 建立血清中丁咯地尔浓度的反相离子对高效液相色谱分析方法 ,并用此法研究了丁咯地尔人体药动学。方法 血样碱化后用二氯甲烷萃取。以甲醇 水 冰醋酸 ( 70∶3 0∶0 .1 ) ,含 0 .0 0 5mol·L- 1十二烷基硫酸钠 ( pH4 )为流动相 ,WatersNo vaPakC18( 5μm 1 50mm× 3 .9mm)色谱柱分离。检测波长 2 78nm。 结果 丁咯地尔在 0 .0 5~ 2 μg·mL- 1浓度范围呈线性 ,r=0 .9996。最低定量浓度 0 .0 2 5μg·mL- 1。低、中、高浓度 ( 0 .1 ,0 .8,1 .6μg·mL- 1)的方法回收率分别为 93 .4 % ,95.0 %和98.3 % ,日间及日内RSD分别 <4 %和 <6%。药动学研究表明 ,口服丁咯地尔国产与进口制剂的药 时曲线符合一级吸收一级消除的二房室模型。结论 此法准确可靠 ,操作简便 ,适用于临床药动学研究及血药浓度监测。 OBJECTIVE: A reversed ion-pair HPLC method was developed for the determination of buflomedil in human serum. Its pharmacokinetic investigation was studied in healthy volunteers. METHODS: The drug in serum was extracted with dichloromethane after alkaline purification, and then detected by UV detector at 278 nm with a Ca18 5 μm 150 mm × 3.9 mm column. The mobile phase was consisted of 0.005 mol&middotL-1 sodium lauryl sulphate in methanol-water-glacial acetic acid (70:30:0.1, pH4) at a flow rate of 1 mL&middotmin--1. RESULT: The calibration curve was linear within the range of 0.05∼2 μg&middotmL-1 and the limit of quantitation was 0.025 μg&middotmL-1. The average recovery of buflomedil at the concentrations of 0.1,0.8,1.6 μg&middotmL-1 was 93.4%, 95.0% and 98.3%, respectively. The RSD of the within-day and between-day variation were less than 4% and 6%, respectively. The results showed that the concentration time curves of the two preparation were fitted to a two compartment model with first order absorption and elimination. CONCLUSION: This experiment established a simple, sensitive and accurate method for the determination of buflomedil levels in human serum. It is suitable for its pharmacokinetic study and therapeutic drug monitoring.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2001年第10期682-685,共4页 Chinese Pharmaceutical Journal
关键词 丁咯地尔 高效液相色谱法 药动学 测定 Biomedical engineering Blood Drug products Drug therapy High performance liquid chromatography Ultraviolet detectors
  • 相关文献

参考文献4

  • 1[1]Venhoutte PM. Cardiovascular pharmacology of buflomedil[J].Bibl Cardiol,1984, 381(2):209. 被引量:1
  • 2[2]Cucinotta D, Avieni Casucci MA, Pedazzi F ,et al. Multicenter clinical placebo-controlled study with buflomedil in th e treatment of mild dementia of vascular origin[J].J Int Med Res,1992,20(2 ):136. 被引量:1
  • 3[3]Gundert-Remy U, Weber E, Lam G,et al .The clinical pharmacokinetics of buflomedil in normal subjects after intravenou s and oral administration[J].Eur J Clin Pharmacol,1981, 20(6): 459. 被引量:1
  • 4[4]Rop PP,Bresson M,Antoine J,et al.Quan titation and ultraviolet spectrum identification of buflomedil in whole blood an d plasma by HPLC[J].J Anal Toxicol,1990,14(1):18. 被引量:1

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部